Discoid Lupus Erythematosus: A Cross-Sectional Study From the Sindh Institute of Skin Diseases, Karachi, Pakistan.

chilblain lupus discoid lupus erythematosus (dle) lichen planus lupus profundus tumid lupus

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
27 Oct 2020
Historique:
entrez: 3 12 2020
pubmed: 4 12 2020
medline: 4 12 2020
Statut: epublish

Résumé

Introduction Discoid lupus erythematosus (DLE) is the most common form of cutaneous lupus erythematosus. It is a chronic, scar-forming, photosensitive autoimmune dermatosis presenting with erythematous and scaly lesions. Predisposed areas include sun-exposed areas like the nose, forehead, and cheeks, as well as the upper body and extremities. The histological findings are typical, with interface dermatitis. Immunoglobulin M (IgM) and immunoglobulin G (IgG) are the most common deposits in the dermoepidermal junction of the involved skin. The most common treatments used are sunscreens, topical corticosteroids, and antimalarials. Immunosuppressive agents, thalidomide, dapsone, and retinoids can be used in refractory cases. The aim of this study was to study the clinicopathologic patterns of DLE in patients presenting to the Institute of Skin Diseases in Sindh, Karachi. Methods A total of 53 consecutive patients with DLE meeting the inclusion criteria were evaluated between February 18, 2018 to March 2, 2019 at the Institute of Skin Diseases. Patients with clinical suspicion of DLE were evaluated and studied prospectively after written informed consent was obtained. Information was then collected from their medical histories, physical examination records, and laboratory investigation reports. Results A total of 53 consecutive patients with clinical and/or histological diagnosis of DLE was included in this study, out of which 75.5% (40) were females with a male to female ratio of 1:3.1. The mean age of the patients at the time of presentation was 36.02 ± 10.04 years, ranging from 14 to 65 years. More than half of the patients (35, 66.0%) were under 40 years of age and 20.8% (11) had a positive family history of DLE. DLE was localized in 36 patients (67.9%) and exposure to the ultraviolet radiation (UVR) was found to be the most frequent induced factor in 46 patients (86.8%), followed by stress which was observed in 14 patients (26.4%). The distribution of commonly affected sites were the face (81.1%), the limbs (71.7%), and the scalp (48.4%) of the patients. Serology antinuclear antibody (ANA) was positive in 56.6% and serology anti-double-stranded deoxyribonucleic acid antibodies (anti-dsDNA) were positive in 45.3% of patients. Smoking, as an induced factor, was more commonly observed among male patients as compared to the female patients with a proportion of 53.8% vs. 2.5%, p < 0.001, while stress was more common among female patients with a proportion of 35% vs. 0%, p = 0.013, respectively. Histopathology with direct immunofluorescence was done in 33 cases which included cases with negative serology or where the diagnosis was in doubt clinically. The main histopathological features observed were periadnexal and perivascular dermal infiltrates, basal cells vacuolization, epidermal atrophy, hyperkeratosis, and follicular plugging. The commonest morphological form observed was the classic discoid plaque form. Conclusion Clinical patterns of DLE in our population comprises of female dominance. Exposure to UVR was the leading inducing factor. The face and limbs were the most commonly involved sites, and the majority of the patients had localized DLE with positive ANA in more than half of those patients. The importance of limiting ultraviolet radiation exposure and toxins (drugs and smoking) should be emphasized in our population.

Identifiants

pubmed: 33269132
doi: 10.7759/cureus.11201
pmc: PMC7704007
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e11201

Informations de copyright

Copyright © 2020, Ashraf et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Dtsch Dermatol Ges. 2007 Dec;5(12):1124-37
pubmed: 18042093
Autoimmune Dis. 2014;2014:321359
pubmed: 24649358
Indian J Pathol Microbiol. 2015 Oct-Dec;58(4):479-82
pubmed: 26549071
Arthritis Care Res (Hoboken). 2015 May;67(6):817-28
pubmed: 25369985
Br J Dermatol. 2011 Jun;164(6):1335-41
pubmed: 21574972
Dermatology. 2005;211(2):118-22
pubmed: 16088157
Dermatol Clin. 2008 Oct;26(4):453-63, vi
pubmed: 18793977
Ann Saudi Med. 2004 Jul-Aug;24(4):289-92
pubmed: 15387498
Br J Dermatol. 2015 Sep;173(3):824-6
pubmed: 25639859
J Coll Physicians Surg Pak. 2010 Jun;20(6):361-4
pubmed: 20642962
Lupus. 2017 Jul;26(8):791-807
pubmed: 28173739
Autoimmun Rev. 2013 Jan;12(3):444-54
pubmed: 23000206
Photodermatol Photoimmunol Photomed. 2013 Feb;29(1):4-11
pubmed: 23281691
Lupus. 2015 Jun;24(7):669-74
pubmed: 25411260
Cochrane Database Syst Rev. 2017 May 05;5:CD002954
pubmed: 28476075
Indian J Dermatol Venereol Leprol. 2011 Nov-Dec;77(6):717-9
pubmed: 22016286
J Multidiscip Healthc. 2019 May 31;12:419-428
pubmed: 31213824
Arch Dermatol Res. 2009 Jan;301(1):99-105
pubmed: 18797892
Clin Rheumatol. 2008 Aug;27(8):949-54
pubmed: 18543054
Treat Endocrinol. 2004;3(1):19-26
pubmed: 15743110
J Invest Dermatol. 2011 Oct;131(10):1981-6
pubmed: 21734714
Dermatol Ther. 2016 Jul;29(4):274-83
pubmed: 27073142
J Dermatol. 2011 Jun;38(6):609-12
pubmed: 21352282
J Am Acad Dermatol. 2015 Apr;72(4):634-9
pubmed: 25648824

Auteurs

Erum Ashraf (E)

Dermatology, Institute of Skin Diseases Sindh, Karachi, PAK.

Afza N Ghouse (AN)

Dermatology, Patel Hospital, Karachi, PAK.

Sitwat Siddiqui (S)

Dermatology, Dr. Ziauddin Hospital, Karachi, PAK.

Sana Siddiqui (S)

Dermatology, Memon Medical Institute Hospital, Karachi, PAK.

Zara Khan (Z)

Dermatology, Medical Glamor Clinics, Riyadh, SAU.

Classifications MeSH